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Infection of rats with the liver fluke. Fasciola hepatica, impaired the responses of the perfused liver to calcium uptake and glucose release induced 
by the synergistic action of glucagon and vasopressin. Treatment of infected rats with dexamethasone prevented the impairment of each of these 
two responses. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Infection of mammalian liver by the common liver 
fluke, Fascioja hepadica, induces several metabolic 
disorders of this organ. These include impairment of 
the detoxification and biotransformation (mixed func- 
tion oxidase) system in rats [l-3] and in sheep [4]. 
Moreover, isolated liver mitochondria from experimen- 
tally infected laboratory rats exhibit uncoupled ox- 
idative phosphorylation [5-71, increased ATPase activi- 
ty /6J, inhibition of respiration and insensitivity of 
mitochondrial ATPase activity to oligomycin [7]. 
Recently we reported that the aberrant respiratory 
behaviour is seen also in isolated liver mitochondria of 
fluke-infected sheep [g]. These and the above- 
mentioned findings led us to consider whether such an 
aberra.tion would also be observed in metabolic ac- 
tivities normally dependent on mitochondrial function 
in the intact liver. To this end we have examined the ef- 
fect of liver fluke infection on the Ca2 + uptake and 
glycogenolytic response by the perfused rat liver induc- 
ed by the synergistic action of glucagon and vasopressin 
[9]. Our results show that these responses are at- 
tenuated following fluke infection. In addition we 
report here that such attenuation can be offset by the 
prior administration of the glucocorticoid dex- 
amethasone to the infected rat. 
Correspondence addres: M.J.E. Hanisch, Division of Biochemistry 
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2.1. Anirnnls 
Animals were bred and housed in the Animal Care Facility at the 
Australian National University. They were kept in pairs in plastic 
cages and allowed a normal diet of rat chow and water. Ambient 
temperature was kept at about 22°C and 12 h periods of light and 
dark were maintained. Four to six week-old male white Wistar rats 
were infected with 30 metacercariae of F. hepatica by gastric gavage 
as described in [7]. Dexamethasone was administered to rats by sub- 
cutaneous injection, 2 mg/kg at 48 h intervals. Treatment began on 
day 35 of the infection and ended about 24 h before the rats were kill- 
ed. Uninfected controls received either the same treatment with dex- 
amethasone or no treatment. 
2.2. Perfusions 
Rats were anaesthetized by an intra-peritoneal injection of sodium 
pcntobarbitone, 50 mg/kg of body weight. The livers were then per- 
fused in situ in a non-recirculating mode as previously described 
[IO.! i]. The perfusate was Krebs-Henscleit buffer [I21 with added 
calcium at physiological concentration (1.28 mM CaClz). The per- 
fusate buffer was 37°C at the point of entry to the liver and was 
gassed continuously prior to perfusion with 95% 0215% COz. The 
perfusion circuit was set at a constant flow rate of 35 ml/min. The 
CaZ + concentration of the effluent perfusate was continuously moni- 
tored using a Radiometer F2112 Ca”’ -selective electrode coupled to 
a Radiometer KNO! (Ag/AgCl) reference electrode via an 
agarose/KCI salt bridge, as previously described [lO,llj. The flow- 
through electrode chamber was continuously stirred by a magnetic 
flea. Data were recorded by a Spectra-Physics SP4100 computing 
integrator which received the translated signal from an Orion model 
301 microprocessor ionanalyser connected to the electrodes. Infusion 
of glucagon (10 nM perfusate concentration) began 15 min after the 
commencement of the perfusion when a steady baseline had been 
eF!zblished. Four minutes later vasopressin (10 nM perfusate concen- 
tration) infusion was begun. Both infusions were ended 11 min later. 
The glucose concentration in the effluent perfusate was measured by 
the glucose oxidase/peroxidase method (God-Perid test kit, 
Boehringer). 
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2.3. Marerials and chemicals 
Dexamethasone (Dcxaphos, 5 m&ml) was from Jurox Pty Ltd., 
Riverstone, NSW, Australia. Vasopressin and glucagon were from 
Sigma Chemical Co.. St. Louis, MO, USA. Ca”’ selectrode mem- 
branes (FZOOZ) and filling solution S43316 were from Radiometer, 
Copenhagen, Denmark. 
2.4. Expression of data 
Data are expressed as the means & SEM for 2 3 determinations 
for each experimental group. 
3. RESULTS 
Representative traces of total Ca” uptake by 
hormone-stimulated perfused rat livers at 6 weeks post- 
infection with F. hepatica re shown in Fig. 1. The trace 
obtained for the control (uninfected) animals is similar 
to those previously obtained in this laboratory (see e.g. 
[I 11) in that immediately following :he administration 
of vasopressin to a perfused liver, into which glucagon 
already is being perfused, there is a significant influx of 
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Fig. 1. Representative traces showing the effect of infection with F. 
hepatica, and of dexamethasone treatment of infected rats, on Ca” 
mobilisation in the perfused rat liver induced by theco-administration 
of glucagon and vasopressin. Livers of (A) control (i.e. uninfected) 
and untreated; (B) 6-week fluke-infected and untreated; (C) 6-week 
fluke-infected and treated with 2 mg of dexamcthasoneikg body wt 
every 4X h fnr the last week of tlw infection, and (D) control ar,d 
treated with dexamethasone as in (C), were perfused with 
Krebs-Henseleit buffer with added 1.2X mM Ca2+. The Ca” con- 
centration in the effluent perfusate was continuously monitored with 
a Ca” -selective electrode as described in section 2. At the times in- 
dicated by horizontal bars, 10 nM glucagon (G, lower bar) and 10 nM 
vasopressin (VP, upper bar) were infused via the inflow cannula. ln- 
flux of Ca”” into the liver is registered as a downward deflection of 
perfusion time(min) 
Fig. 2. Glucose release by perfused fluke-infected rat liver in response 
to glycogenolytic hormones. Livers of 6-week infected animals were 
perfused exactly as described in Fig. 1. Glucose release was measured 
in samples of the effluent medium at the times indicated as described 
in section 2. The designations A-D arc identical to those in Fig. 1. 
the recorder pen. Values are the means -r-SEM for 2 3 determinations. 
Ca2 + from the external medium. The amount of Cat+ 
taken up (from measurements of the area above the 
curve [IS]), was 2250 If: 42 nmol/g of liver (mean of 3 
experiments). The features of this phenomenon have 
been described in detail elsewhere [9]. When the experi- 
ment is repeated with livers obtained from rats infected 
for 6 weeks with F. hepatica (trace E3 in Fig. 1) it is evi- 
dent that the Cat + uptake response is markedly at- 
tenuated. The amount of Ca2+ taken up was 897 k 87 
nmol/g of liver (mean of 5 experiments). Trace C is 
from an experiment in which &week infected rats were 
treated with dexamethasone for one week prior to liver 
perfusion. Such treatment results in a normal pattern of 
uptake of Ca2 ‘; in this instance Ca’” uptake was 
2645 k 511 nmol/g of liver (mean of 4 experiments). 
Trace D shows that the treatment of control rats with 
the glucocorticoid did not change the control value for 
Ca2 + uptake which was 2013 f 120 nmol/g of liver 
(mean of 5 experiments). 
The patterns of release of glucose in response to the 
actions of glucagon and vasopressin in the same ex- 
periments undertaken in Fig. 1 are presented in Fig. 2. 
The glycogenolytic response of infected, untreated rat 
livers (group B) was reduced to 4% of uninfected nor- 
mal controls (group A). Dexamethasone treatment of 
infected rats (group C) countered this attenuation to a 
significant extent but not to the degree seen in the Ca2 + 
uptake response, while dexamethasone treatment alone 
to control rats had no effect (group D). Consistent with 
these results, we have found (C.J. Rule, C.A. Behm and 
F.L. Bygrave, unpublished observations) that 
glycogeaolysis in the perfused rat liver induced by the 
Ca2 + -mobilising agonist phenylephrine, also is 
markedly attenuated following infection by F. hepatica. 
4. D1SCUSSIQM 
In this paper we have presented evidence that certain 
aspects of whole liver metabolism are impaired follow- 
ing fluke infection and we have identified additional 
95 
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sites of metabolic impairment in infected livers. We 
have also shown that administration of the immunosup- 
pressive glucocorticoid, dexamethasone, reverses or 
ameliorates the metabolic lesions. 
Infection leads to attenua.tion of the characteristic 
Ca*+ uptake response in perfused liver that is induced 
by the synergistic action of the glycogenolytic hormones 
glucagon and vasopressin (cf. [ 131). Uptake of Cat + by 
the mitochondria is considered to be intimately involv- 
ed in this response [9J. Therefore it appears that at- 
tenuation of whole liver Ca* + uptake could well reflect 
the impairment of mitochondrial energy-linked func- 
tions observed previously by others [S] and ourselves [7] 
in mitochondria from infected rat liver, from sheep 
liver [8] and in intact hepatic cells and whole liver from 
rats (M.J.E. Hanisch, F. Topfer, CA. Behm and F.L. 
Bygrave, submitted). 
Hepatic output of glucose induced by the 
glycogenolytic hormones glucagon and vasopressin is 
attenuated also in infected rats. Indeed, there was little 
discernible output of glucose by infected livers. It is 
known that the glycogen content of infected rat livers if 
diminished ([I41 and J.E. Millard, C.J. Rule, C.A. 
Behm and F.L. Bygrave, unpublished observations). 
Whether the attenuated response is due to this or to im- 
pairment of the glycogenolytic response at the en- 
zymatic, receptor or signal transduction levels is under 
investigation. 
The effect of dexamethasone in ameliorating the 
observed metabolic lesions is interesting in that it sheds 
new light on how the lesions are induced. Dex- 
amethasone has a large number of effects on a variety 
of aspects of mammalian metabolism and also on the 
cellular immune system. It was shown, for example, 
that incubation with glucocorticoid prevented the 
antigen-induced rise in free intracellular calcium in rat 
basophilic leukemia cells [ 151. Particularly relevant for 
this work may be the observations that dexamethasone 
impairs the inflammatory response by killing lym- 
phocytes /16,17] and eosinophils [ I$] as well as by in- 
hibiting the production of inflammatory cytokines [I91 
and eicosanoids [20]. Therefore, our observations pro- 
vide some evidence suggestive of a role for the cellular 
immune response in the aetiology of the metabolic le- 
sions observed in fluke-infected rat livers. Further ex- 
perimental examination of this question is in progress in 
our laboratory. 
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